Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Degradation of PD‐L1 and Activation of the STING Pathway by Carbon‐Dot‐Based PROTACs for Cancer Immunotherapy
Wen Su, Mixiao Tan, Zhihang Wang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 11
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Electron Lock Manipulates the Catalytic Selectivity of Nanozyme
Guopeng Xu, Kehan Liu, Bingqing Jia, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3814-3825
Closed Access | Times Cited: 19
Nano-PROTACs: state of the art and perspectives
Jie Zhong, Ruiqi Zhao, Yuji Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 9, pp. 4378-4391
Closed Access | Times Cited: 13
Cell Membrane as A Promising Therapeutic Target: From Materials Design to Biomedical Applications
Xiaofeng Wu, Jingjing Hu, Juyoung Yoon
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 18
Closed Access | Times Cited: 12
Covalent LYTAC Enabled by DNA Aptamers for Immune Checkpoint Degradation Therapy
Yuqing Li, Xueliang Liu, Lu Yu, et al.
Journal of the American Chemical Society (2023)
Closed Access | Times Cited: 26
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 23
Red/NIR‐I‐Fluorescence Carbon Dots Based on Rhein with Active Oxygen Scavenging and Colitis Targeting for UC Therapeutics
Jiashan Xia, Jiayu Wang, Fengyuan Liu, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 19
Closed Access | Times Cited: 8
Nanotechnology of carbon dots with their hybrids for biomedical applications: A review
Haixin Chen, Kun Luo, Can Xie, et al.
Chemical Engineering Journal (2024) Vol. 496, pp. 153915-153915
Closed Access | Times Cited: 8
Effects of the periodic fasting-mimicking diet on health, lifespan, and multiple diseases: a narrative review and clinical implications
Ruohua Wang, Xinyi Lv, Wenyu Xu, et al.
Nutrition Reviews (2024)
Closed Access | Times Cited: 6
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access
Research Progress in Bifunctional small molecules for cancer immunotherapy
Binbin Cheng, Hongqiao Li, Yun Hong, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117289-117289
Closed Access
Nanomedicine in Immunotherapy for Non‐Small Cell Lung Cancer: Applications and Perspectives
Shuangsi Liao, Xiaoling Li, You Lü, et al.
Small Methods (2025)
Open Access
The glowing frontier: Carbon dots' journey for customized cancer treatments
Anqi Liang, Jie Yang, Xiao Zhu, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106658-106658
Closed Access
Selective Protein of Interest Degradation through the Split-and-Mix Liposome Proteolysis Targeting Chimera Approach
Chunli Song, Zijun Jiao, Zhanfeng Hou, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 40, pp. 21860-21870
Closed Access | Times Cited: 19
Persistent Degradation of HER2 Protein by Hybrid nanoPROTAC for Programmed Cell Death
Zhihang Wang, Mixiao Tan, Wen Su, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6263-6273
Closed Access | Times Cited: 16
Dual‐Programmable Semiconducting Polymer NanoPROTACs for Deep‐Tissue Sonodynamic‐Ferroptosis Activatable Immunotherapy
Fengshuo Wang, Guoqiang Dong, Mengbin Ding, et al.
Small (2023) Vol. 20, Iss. 8
Closed Access | Times Cited: 15
Advanced nanomaterials targeting activation of STING for enhanced cancer immunotherapy
Jia Tan, Meifang Wang, Binbin Ding, et al.
Coordination Chemistry Reviews (2023) Vol. 493, pp. 215316-215316
Closed Access | Times Cited: 14
Recent advances and mechanisms of action of PD-L1 degraders as potential therapeutic agents
Feng Zhang, Ruiya Jiang, Shishi Sun, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116267-116267
Closed Access | Times Cited: 5
Multi-step strategies for synergistic treatment of urinary tract infections based on D-xylose-decorated antimicrobial peptide carbon dots
Chunhui Miao, Yajie Zhang, Guowen Liu, et al.
Biomaterials (2024) Vol. 308, pp. 122547-122547
Closed Access | Times Cited: 5
Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway
Zhijie Wang, L. Yuan, Xiaotong Liao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6027-6043
Closed Access | Times Cited: 5
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Carbon‐based nanodots for biomedical applications and clinical transformation prospects
Haizhen Ding, Tenghui Xiao, Fangfang Ren, et al.
BMEMat (2024) Vol. 2, Iss. 3
Open Access | Times Cited: 5
Ultrasound-Activated PROTAC Prodrugs Overcome Immunosuppression to Actuate Efficient Deep-Tissue Sono-Immunotherapy in Orthotopic Pancreatic Tumor Mouse Models
Ye Liu, Haiyang Wang, Mengchao Ding, et al.
Nano Letters (2024) Vol. 24, Iss. 28, pp. 8741-8751
Closed Access | Times Cited: 5
A bibliometric analysis of the Fasting-Mimicking Diet
Xiaoxiao Lin, Yue Gao
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 4
Cell Membrane as A Promising Therapeutic Target: From Materials Design to Biomedical Applications
Xiaofeng Wu, Jingjing Hu, Juyoung Yoon
Angewandte Chemie (2024) Vol. 136, Iss. 18
Closed Access | Times Cited: 4
Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions
Rajamanikkam Kamaraj, Subhrojyoti Ghosh, Souvadra Das, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 8, pp. 1089-1115
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top